1 Jun 2012: Global communications and advertising agency Havas has acquired a majority stake in Creative Lynx, the leading digital health and wellness communications agency in Europe, with expertise in social media, closed-loop marketing and mobile.

The move further strengthens Havas’ position in the healthcare communications sector, adding to its stable of businesses in the sector including  Havas Worldwide Health, Euro RSCG Life andHealth4Brands. The network handles around 30 global brands including Sanofi, Pfizer and Novartis.

David Jones, Havas CEO, commented: “Both our healthcare and digital businesses have been experiencing very strong growth and this acquisition that sits at the intersection of those two key areas will further strengthen our capabilities. The fact that Creative Lynx decided to join Havas over many other suitors underlines the unique appeal and exciting momentum of our group.”

Creative Lynx’s blue-chip client roster includes Johnson & Johnson, GSK, GE and AstraZeneca. “This partnership will combine industry-leading strategy and insight with award-winning creativityand digital innovation, to deliver best-in-class campaigns,” said Donna Murphy, global CEO, Havas Health. “We believe that Creative Lynx’s social media prowess, as well as its entrepreneurial style, deep talent pool and future-forward business model, will add great value for our clients.”